M&A Deal Summary

BigHat Biosciences Acquires Frugi Biotechnology

On March 28, 2022, BigHat Biosciences acquired life science company Frugi Biotechnology

Acquisition Highlights
  • This is BigHat Biosciences’ 1st transaction in the Life Science sector.
  • This is BigHat Biosciences’ 1st transaction in the United States.
  • This is BigHat Biosciences’ 1st transaction in Iowa.

M&A Deal Summary
Date 2022-03-28
Target Frugi Biotechnology
Sector Life Science
Buyer(s) BigHat Biosciences
Deal Type Add-on Acquisition

Target

Frugi Biotechnology

Ames, Iowa, United States
Frugi Biotechnology is a biotechnology company developing cost-effective and high-quality cell-free protein synthesis (CFPS) technology. Frugi Biotechnology is based in Ames, Iowa.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BigHat Biosciences

San Mateo, California, United States
Category Company
Founded 2019
Sector Life Science
DESCRIPTION

BigHat Biosciences is a biotechnology company developing safer, more effective next-generation antibody therapies for patients using machine learning and synthetic biology. BigHat Biosciences was founded in 2019 and is based in San Mateo, California.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Iowa) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal